Table 4.
Multivariate analysis: Adjusted OR of poor outcome at 3-months for baseline associated variables in the univariate analysis in IS patients.
| Independent variables | OR | 95% CI | p-value |
|---|---|---|---|
| Female not adjusted | 2.13 | 1.88–2.42 | <0.0001 |
| DEMOGRAPHIC VARIABLES | |||
| Female | 1.54 | 1.32–1.80 | <0.0001 |
| Age | 1.03 | 1.02–1.04 | <0.0001 |
| Previous mRS | 1.39 | 1.19–1.61 | <0.0001 |
| History of atrial fibrillation | 2.18 | 1.79–2.67 | <0.0001 |
| Time from stroke onset | 1.00 | 1.00–1.00 | 0.025 |
| CLINICAL VARIABLES | |||
| Female | 2.17 | 1.64–2.87 | <0.0001 |
| NIHSS at admission | 1.06 | 1.03–1.08 | <0.0001 |
| Axillary temperature at admission | 1.38 | 1.09–1.75 | 0.007 |
| Glucose levels at admission | 1.00 | 1.00–1.01 | 0.012 |
| Sedimentation rate | 1.00 | 1.00–1.01 | 0.004 |
| Cardioembolic stroke | 4.62 | 3.44–6.21 | <0.0001 |
| TC volume 4th−7th day | 1.02 | 1.02–1.03 | <0.0001 |
| Fibrinolytic treatment | 0.21 | 0.15–0.3 | <0.0001 |
| Early neurological deterioration | 4.56 | 2.58–8.06 | <0.0001 |
| MOLECULAR MARKERS | |||
| Female | 1.91 | 1.57–2.31 | <0.0001 |
| Leukocytes | 1.06 | 1.02–1.09 | 0.001 |
| Fibrinogen | 1.00 | 1.00–1.01 | 0.006 |
| C-reactive protein | 1.09 | 1.06–1.12 | <0.0001 |
| NT-proBNP levels (pg/mL) | 1.00 | 1.00–1.00 | <0.0001 |